US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Rapport Therapeutics, Inc.

48.72

+0.05000.10%

Volume:38.49K

Turnover:1.87M

Market Cap:2.34B

PE:-15.96

High:49.38

Open:48.17

Low:47.90

Close:48.67

52wk High:52.93

52wk Low:14.11

Shares:47.98M

Float Shares:30.39M

Volume Ratio:0.33

T/O Rate:0.13%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.0525

EPS(LYR):-2.8633

ROE:-39.96%

ROA:-25.78%

PB:5.53

PE(LYR):-17.02

Loading ...

Overview Company News Filings

Rapport Therapeutics Chief Development Officer Krishnaswamy Yeleswaram Disposes of Common Shares Worth $2.51 Million

Rapport Therapeutics to Host Virtual KOL Event on Bipolar Mania and RAP-219 Program

Rapport Therapeutics Chief Development Officer Krishnaswamy Yeleswaram Disposes of 404 Common Shares Worth $20,159.6

Analysts Have Conflicting Sentiments on These NA Companies: ServiceTitan, Inc. Class A (TTAN), Rapport Therapeutics, Inc. (RAPP) and Amentum Holdings, Inc. (AMTM)

Analysts Offer Insights on NA Companies: Rapport Therapeutics, Inc. (RAPP) and SpaceX (SPCX)

Does Widening Losses And Higher EPS Drag Change The Bull Case For Rapport Therapeutics (RAPP)?

Simply Wall St.

Rapport Therapeutics Price Target Maintained with a $65.00/Share by BTIG

Rapport Therapeutics price target raised to $75 from $68 at Raymond James

Rapport Therapeutics, Inc. (RAPP) Receives a Buy from Stifel Nicolaus

Rapport Therapeutics CEO Abraham Ceesay Sells 51,499 Shares Worth $2.41 Million

Rapport Therapeutics Price Target Raised to $66.00/Share from $40.00 by HC Wainwright & Co.

Douglas Tsao Boosts Rapport Therapeutics Price Target to $66 on Strong RAP-219 Differentiation and Robust Phase 2 Data

Analysts Offer Insights on NA Companies: Rapport Therapeutics, Inc. (RAPP) and Honeywell Aerospace (HONA)

Truist Financial Keeps Their Buy Rating on Rapport Therapeutics, Inc. (RAPP)

Rapport Therapeutics Price Target Maintained with a $65.00/Share by BTIG

Rapport Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Rapport Therapeutics Q2 EPS $(1.19) Misses $(0.96) Estimate

Benzinga Earnings

Rapport Therapeutics Q2 FY26 Net Loss Widens to $56.6 Million; R&D Expense More than Doubled to $51.4 Million

Rapport Therapeutics Reports Second Quarter 2026 Financials and Provides Business Update

THOMSON REUTERS

Rapport Therapeutics CEO Abraham Ceesay Sells 2,210 Shares Worth $92,999.37

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/RAPP/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RAPP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RAPP\",,,,,undefined,":{"symbol":"RAPP","market":"US","secType":"STK","nameCN":"Rapport Therapeutics, Inc.","latestPrice":48.72,"timestamp":1788278364381,"preClose":48.67,"halted":0,"volume":38490,"delay":0,"changeRate":0.0010273268954180635,"floatShares":30393800,"shares":47978286,"eps":-3.052456,"marketStatus":"Trading","change":0.05,"latestTime":"09-01 11:59:30 EDT","open":48.17,"high":49.375,"low":47.9,"amount":1873177.4340000001,"amplitude":0.030306,"askPrice":48.87,"askSize":192,"bidPrice":48.53,"bidSize":300,"shortable":3,"etf":0,"ttmEps":-3.052456,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788292800000},"marketStatusCode":2,"adr":0,"listingDate":1717732800000,"exchange":"NASDAQ","adjPreClose":48.67,"preHourTrading":{"tag":"盘前","latestPrice":48.67,"preClose":48.67,"latestTime":"08:48 EDT","volume":6,"amount":292.039992,"timestamp":1788266903221,"change":0,"changeRate":0,"amplitude":0.000205},"postHourTrading":{"tag":"盘后","latestPrice":48.67,"preClose":48.67,"latestTime":"17:01 EDT","volume":25449,"amount":1238602.316611,"timestamp":1788210107309,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.325685,"impliedVol":0.8938,"impliedVolPercentile":0.8452},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RAPP\",,,,,undefined,":{"symbol":"RAPP","floatShares":30393800,"roa":"-25.78%","roe":"-39.96%","lyrEps":-2.863342,"volumeRatio":0.325685,"shares":47978286,"dividePrice":0,"high":49.375,"amplitude":0.030306,"preClose":48.67,"low":47.9,"week52Low":14.11,"pbRate":"5.53","psRate":"116.88","week52High":52.93,"institutionHeld":0,"latestPrice":48.72,"committee":0.219512,"eps":-3.052456,"divideRate":0,"volume":38490,"delay":0,"ttmEps":-3.052456,"open":48.17,"prevYearClose":30.34,"prevWeekClose":48.77,"prevMonthClose":48.67,"prevQuarterClose":41.67,"fiveDayClose":51.17,"twentyDayClose":42.2,"sixtyDayClose":36.1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RAPP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"RAPP","fiscalQuarterEnding":"2026/06","expectedEps":-0.93,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"pre","actualEps":-1.19},{"market":"US","date":"2026-05-07","symbol":"RAPP","fiscalQuarterEnding":"2026/03","expectedEps":-0.56,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-0.42},{"market":"US","date":"2026-03-10","symbol":"RAPP","fiscalQuarterEnding":"2025/12","expectedEps":-0.65,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773115200000,"reportTimeType":"pre","actualEps":-0.72},{"market":"US","date":"2025-11-06","symbol":"RAPP","fiscalQuarterEnding":"2025/09","expectedEps":-0.77,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.71},{"market":"US","date":"2025-08-07","symbol":"RAPP","fiscalQuarterEnding":"2025/06","expectedEps":-0.87,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":-0.75}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RAPP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RAPP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4615,"buy":0.5385,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5385,"analysts":13,"updateTime":1785384000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RAPP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RAPP","date":"2026-08-31","current":-15.960918,"percent":0.101968,"low":-19.654107,"twenty":-15.697551,"median":-12.838427,"eighty":-6.427984,"high":-3.640031,"avg":-11.719986,"sd":4.388766,"marketCap":2339901008},"quantilePoints":[{"date":"2024-06-07","current":-14.341434,"twenty":-13.293406,"median":-11.721364,"eighty":-11.721364,"marketCap":735830305},{"date":"2024-06-14","current":-17.322989,"twenty":-16.966549,"median":-15.024031,"eighty":-12.769392,"marketCap":888807905},{"date":"2024-06-21","current":-15.733266,"twenty":-17.881887,"median":-15.772475,"eighty":-14.348329,"marketCap":807242405},{"date":"2024-06-28","current":-16.581593,"twenty":-17.17471,"median":-16.18238,"eighty":-14.635158,"marketCap":850768389},{"date":"2024-07-05","current":-17.059223,"twenty":-17.829134,"median":-16.431888,"eighty":-15.672154,"marketCap":875274616},{"date":"2024-07-12","current":-18.299635,"twenty":-18.057796,"median":-16.595851,"eighty":-15.733266,"marketCap":938917651},{"date":"2024-07-19","current":-14.343149,"twenty":-18.092899,"median":-16.610109,"eighty":-15.733266,"marketCap":735918314},{"date":"2024-07-26","current":-16.431888,"twenty":-18.057796,"median":-16.50674,"eighty":-14.592658,"marketCap":843087333},{"date":"2024-08-02","current":-15.740395,"twenty":-18.021611,"median":-16.417631,"eighty":-14.614044,"marketCap":807608170},{"date":"2024-08-09","current":-11.062669,"twenty":-17.829134,"median":-16.189509,"eighty":-14.507112,"marketCap":697147270},{"date":"2024-08-16","current":-12.078391,"twenty":-17.822005,"median":-15.897228,"eighty":-14.341434,"marketCap":761156070},{"date":"2024-08-23","current":-12.943207,"twenty":-17.322989,"median":-15.776039,"eighty":-12.769083,"marketCap":815654991},{"date":"2024-08-30","current":-12.623979,"twenty":-17.301602,"median":-15.672154,"eighty":-12.252515,"marketCap":795537939},{"date":"2024-09-06","current":-11.799793,"twenty":-17.107699,"median":-14.956226,"eighty":-12.030797,"marketCap":743599370},{"date":"2024-09-13","current":-11.027844,"twenty":-17.007896,"median":-14.603351,"eighty":-11.813723,"marketCap":694952683},{"date":"2024-09-20","current":-12.322165,"twenty":-16.6871,"median":-14.421566,"eighty":-11.752199,"marketCap":776518182},{"date":"2024-09-27","current":-12.380206,"twenty":-16.587296,"median":-14.342291,"eighty":-11.752199,"marketCap":780175827},{"date":"2024-10-04","current":-12.072587,"twenty":-16.581593,"median":-13.041877,"eighty":-11.742318,"marketCap":760790305},{"date":"2024-10-11","current":-12.798103,"twenty":-16.461829,"median":-12.783593,"eighty":-11.721364,"marketCap":806510876},{"date":"2024-10-18","current":-15.061713,"twenty":-16.461829,"median":-13.041877,"eighty":-11.742318,"marketCap":949159059},{"date":"2024-10-25","current":-14.057599,"twenty":-16.431888,"median":-14.106934,"eighty":-11.752199,"marketCap":885881788},{"date":"2024-11-01","current":-14.289764,"twenty":-16.420482,"median":-14.289764,"eighty":-11.78122,"marketCap":900512371},{"date":"2024-11-08","current":-13.587752,"twenty":-16.360601,"median":-14.196898,"eighty":-11.792828,"marketCap":976225637},{"date":"2024-11-15","current":-10.665545,"twenty":-16.293733,"median":-13.709352,"eighty":-11.752199,"marketCap":766276774},{"date":"2024-11-22","current":-11.755009,"twenty":-16.213426,"median":-13.641207,"eighty":-11.719637,"marketCap":844550392},{"date":"2024-11-29","current":-11.627735,"twenty":-16.188083,"median":-13.405914,"eighty":-11.573511,"marketCap":835406277},{"date":"2024-12-06","current":-10.416089,"twenty":-16.139607,"median":-12.943207,"eighty":-11.450385,"marketCap":748354310},{"date":"2024-12-13","current":-9.555718,"twenty":-15.982774,"median":-12.73716,"eighty":-11.371152,"marketCap":686540097},{"date":"2024-12-20","current":-9.199351,"twenty":-15.858733,"median":-12.415031,"eighty":-11.254059,"marketCap":660936577},{"date":"2024-12-27","current":-9.688083,"twenty":-15.824515,"median":-12.350651,"eighty":-11.045256,"marketCap":696049976},{"date":"2025-01-03","current":-9.917175,"twenty":-15.797425,"median":-12.316361,"eighty":-10.975704,"marketCap":712509382},{"date":"2025-01-10","current":-7.539701,"twenty":-15.740395,"median":-12.304752,"eighty":-10.859002,"marketCap":541697328},{"date":"2025-01-17","current":-6.460419,"twenty":-15.733266,"median":-12.215086,"eighty":-10.644772,"marketCap":464155239},{"date":"2025-01-24","current":-7.076424,"twenty":-15.684376,"median":-12.087097,"eighty":-10.43238,"marketCap":508412752},{"date":"2025-01-31","current":-8.354253,"twenty":-15.597056,"median":-11.915876,"eighty":-10.137105,"marketCap":600219659},{"date":"2025-02-07","current":-8.211706,"twenty":-15.257893,"median":-11.843324,"eighty":-9.686047,"marketCap":589978251},{"date":"2025-02-14","current":-8.094614,"twenty":-15.103195,"median":-11.828814,"eighty":-9.441681,"marketCap":581565666},{"date":"2025-02-21","current":-6.455328,"twenty":-15.070846,"median":-11.799793,"eighty":-9.297098,"marketCap":463789474},{"date":"2025-02-28","current":-5.106225,"twenty":-15.037336,"median":-11.771597,"eighty":-9.077168,"marketCap":366861863},{"date":"2025-03-07","current":-4.373128,"twenty":-15.01412,"median":-11.747556,"eighty":-8.771711,"marketCap":314191765},{"date":"2025-03-14","current":-4.898381,"twenty":-14.977526,"median":-11.717047,"eighty":-8.416363,"marketCap":383577552},{"date":"2025-03-21","current":-4.530187,"twenty":-14.817535,"median":-11.627735,"eighty":-8.164869,"marketCap":354745367},{"date":"2025-03-28","current":-4.68399,"twenty":-14.676319,"median":-11.461087,"eighty":-7.790176,"marketCap":366789191},{"date":"2025-04-04","current":-4.189957,"twenty":-14.640334,"median":-11.410917,"eighty":-7.133443,"marketCap":328102968},{"date":"2025-04-11","current":-4.315796,"twenty":-14.632186,"median":-11.370643,"eighty":-6.989878,"marketCap":337957006},{"date":"2025-04-17","current":-4.730597,"twenty":-14.622599,"median":-11.327444,"eighty":-6.74653,"marketCap":370438835},{"date":"2025-04-25","current":-4.949801,"twenty":-14.60549,"median":-11.189913,"eighty":-6.457364,"marketCap":387604034},{"date":"2025-05-02","current":-5.280719,"twenty":-14.55844,"median":-11.048158,"eighty":-5.528775,"marketCap":413517298},{"date":"2025-05-09","current":-4.693792,"twenty":-14.472894,"median":-10.976093,"eighty":-5.332796,"marketCap":374099938},{"date":"2025-05-16","current":-4.560992,"twenty":-14.4176,"median":-10.940782,"eighty":-5.2164,"marketCap":363515647},{"date":"2025-05-23","current":-5.092192,"twenty":-14.397354,"median":-10.8247,"eighty":-5.097805,"marketCap":405852811},{"date":"2025-05-30","current":-3.896992,"twenty":-14.370288,"median":-10.665545,"eighty":-4.981023,"marketCap":310594193},{"date":"2025-06-06","current":-5.646289,"twenty":-14.346875,"median":-10.527934,"eighty":-4.950803,"marketCap":450014853},{"date":"2025-06-13","current":-5.101351,"twenty":-14.342806,"median":-10.416089,"eighty":-4.981023,"marketCap":406582762},{"date":"2025-06-20","current":-5.050978,"twenty":-14.341434,"median":-10.309179,"eighty":-5.014344,"marketCap":402568031},{"date":"2025-06-27","current":-5.408165,"twenty":-14.289764,"median":-9.866266,"eighty":-5.000606,"marketCap":431036124},{"date":"2025-07-03","current":-5.513507,"twenty":-14.247974,"median":-9.698265,"eighty":-5.011596,"marketCap":439432031},{"date":"2025-07-11","current":-7.043002,"twenty":-14.172521,"median":-9.586263,"eighty":-5.043651,"marketCap":561334272},{"date":"2025-07-18","current":-6.795718,"twenty":-14.077333,"median":-9.430989,"eighty":-5.078884,"marketCap":541625526},{"date":"2025-07-25","current":-7.610838,"twenty":-13.779001,"median":-9.362262,"eighty":-5.090926,"marketCap":606591391},{"date":"2025-08-01","current":-6.57591,"twenty":-13.6976,"median":-9.168805,"eighty":-5.092192,"marketCap":524106641},{"date":"2025-08-08","current":-6.368661,"twenty":-13.694662,"median":-9.054259,"eighty":-5.099519,"marketCap":562429202},{"date":"2025-08-15","current":-6.17446,"twenty":-13.609134,"median":-8.982986,"eighty":-5.10525,"marketCap":545278924},{"date":"2025-08-22","current":-6.170327,"twenty":-13.473486,"median":-8.4968,"eighty":-5.115317,"marketCap":544913945},{"date":"2025-08-29","current":-6.943168,"twenty":-13.38251,"median":-8.407708,"eighty":-5.122916,"marketCap":613165056},{"date":"2025-09-05","current":-6.343907,"twenty":-13.171889,"median":-8.282979,"eighty":-5.126995,"marketCap":560243072},{"date":"2025-09-12","current":-9.588184,"twenty":-13.020376,"median":-8.364435,"eighty":-5.143059,"marketCap":846751744},{"date":"2025-09-19","current":-14.281097,"twenty":-13.398113,"median":-8.486618,"eighty":-5.165131,"marketCap":1261192245},{"date":"2025-09-26","current":-13.038354,"twenty":-13.650327,"median":-8.934622,"eighty":-5.176938,"marketCap":1151443158},{"date":"2025-10-03","current":-14.902468,"twenty":-13.718742,"median":-9.051713,"eighty":-5.195691,"marketCap":1316066789},{"date":"2025-10-10","current":-13.962579,"twenty":-13.896787,"median":-9.158623,"eighty":-5.223161,"marketCap":1233063277},{"date":"2025-10-17","current":-12.986138,"twenty":-13.856058,"median":-9.228454,"eighty":-5.262092,"marketCap":1146831851},{"date":"2025-10-24","current":-13.675391,"twenty":-13.856058,"median":-9.397898,"eighty":-5.294604,"marketCap":1207701093},{"date":"2025-10-31","current":-14.035682,"twenty":-13.934383,"median":-9.502263,"eighty":-5.303959,"marketCap":1239519106},{"date":"2025-11-07","current":-11.969573,"twenty":-13.970933,"median":-9.588184,"eighty":-5.319746,"marketCap":1169427252},{"date":"2025-11-14","current":-12.034803,"twenty":-13.934383,"median":-9.698265,"eighty":-5.33408,"marketCap":1175800274},{"date":"2025-11-21","current":-13.098276,"twenty":-13.915585,"median":-9.917175,"eighty":-5.342242,"marketCap":1279701555},{"date":"2025-11-28","current":-14.493474,"twenty":-13.931568,"median":-10.309179,"eighty":-5.356195,"marketCap":1416012409},{"date":"2025-12-05","current":-14.000764,"twenty":-13.954437,"median":-10.426271,"eighty":-5.376155,"marketCap":1367874660},{"date":"2025-12-12","current":-14.039791,"twenty":-13.99491,"median":-10.604143,"eighty":-5.393122,"marketCap":1371687551},{"date":"2025-12-19","current":-14.459326,"twenty":-14.050476,"median":-10.719003,"eighty":-5.431972,"marketCap":1412676130},{"date":"2025-12-26","current":-15.088628,"twenty":-14.119227,"median":-10.841851,"eighty":-5.476848,"marketCap":1474158998},{"date":"2026-01-02","current":-14.800808,"twenty":-14.281097,"median":-10.940782,"eighty":-5.513507,"marketCap":1446038926},{"date":"2026-01-09","current":-13.81051,"twenty":-14.281097,"median":-10.976093,"eighty":-5.513507,"marketCap":1349286816},{"date":"2026-01-16","current":-13.103154,"twenty":-14.237527,"median":-11.048158,"eighty":-5.513507,"marketCap":1280178166},{"date":"2026-01-23","current":-13.620256,"twenty":-14.172521,"median":-11.156822,"eighty":-5.535473,"marketCap":1330698972},{"date":"2026-01-30","current":-13.049493,"twenty":-14.13499,"median":-11.312246,"eighty":-5.592253,"marketCap":1274935441},{"date":"2026-02-06","current":-12.464095,"twenty":-14.128014,"median":-11.370643,"eighty":-5.617345,"marketCap":1217742075},{"date":"2026-02-13","current":-13.644647,"twenty":-14.087483,"median":-11.410917,"eighty":-5.641114,"marketCap":1333082029},{"date":"2026-02-20","current":-14.630067,"twenty":-14.14031,"median":-11.45735,"eighty":-5.660027,"marketCap":1429357528},{"date":"2026-02-27","current":-14.391029,"twenty":-14.240388,"median":-11.53826,"eighty":-5.735139,"marketCap":1406003571},{"date":"2026-03-06","current":-14.464204,"twenty":-14.259247,"median":-11.689515,"eighty":-5.790087,"marketCap":1413152741},{"date":"2026-03-13","current":-12.292686,"twenty":-14.284564,"median":-11.721364,"eighty":-5.811144,"marketCap":1370425569},{"date":"2026-03-20","current":-11.773881,"twenty":-14.259247,"median":-11.747556,"eighty":-5.859217,"marketCap":1312587588},{"date":"2026-03-27","current":-12.434179,"twenty":-14.240388,"median":-11.754185,"eighty":-5.89508,"marketCap":1386199565},{"date":"2026-04-02","current":-13.578981,"twenty":-14.21307,"median":-11.781033,"eighty":-5.908305,"marketCap":1513825524},{"date":"2026-04-10","current":-14.672331,"twenty":-14.286297,"median":-11.799793,"eighty":-5.924837,"marketCap":1635715486},{"date":"2026-04-17","current":-16.95336,"twenty":-14.342463,"median":-11.834618,"eighty":-5.953085,"marketCap":1890011406},{"date":"2026-04-24","current":-15.589888,"twenty":-14.384981,"median":-11.842483,"eighty":-5.987204,"marketCap":1738007454},{"date":"2026-05-01","current":-14.207247,"twenty":-14.395165,"median":-11.879676,"eighty":-6.003597,"marketCap":1583866549},{"date":"2026-05-08","current":-17.794666,"twenty":-14.442977,"median":-11.889648,"eighty":-6.018516,"marketCap":1908958386},{"date":"2026-05-15","current":-16.919116,"twenty":-14.478378,"median":-11.936812,"eighty":-6.027747,"marketCap":1815031955},{"date":"2026-05-22","current":-16.361832,"twenty":-14.513564,"median":-11.969573,"eighty":-6.033101,"marketCap":1755248294},{"date":"2026-05-29","current":-17.605688,"twenty":-14.602401,"median":-12.072587,"eighty":-6.039697,"marketCap":1888685426},{"date":"2026-06-05","current":-16.714035,"twenty":-14.636423,"median":-12.104204,"eighty":-6.052541,"marketCap":1793031568},{"date":"2026-06-12","current":-15.697551,"twenty":-14.689254,"median":-12.211886,"eighty":-6.082711,"marketCap":1683986170},{"date":"2026-06-18","current":-16.437623,"twenty":-14.725074,"median":-12.249449,"eighty":-6.104202,"marketCap":1763378872},{"date":"2026-06-26","current":-17.347109,"twenty":-14.756903,"median":-12.285702,"eighty":-6.170327,"marketCap":1860945807},{"date":"2026-07-02","current":-17.561106,"twenty":-14.865035,"median":-12.307654,"eighty":-6.173633,"marketCap":1883902733},{"date":"2026-07-10","current":-18.747004,"twenty":-14.94702,"median":-12.322165,"eighty":-6.184379,"marketCap":2011122364},{"date":"2026-07-17","current":-17.891017,"twenty":-15.011798,"median":-12.351888,"eighty":-6.210003,"marketCap":1919294660},{"date":"2026-07-24","current":-18.4483,"twenty":-15.085362,"median":-12.382727,"eighty":-6.318283,"marketCap":1979078322},{"date":"2026-07-31","current":-19.072457,"twenty":-15.112377,"median":-12.415031,"eighty":-6.358759,"marketCap":2046036022},{"date":"2026-08-07","current":-16.213135,"twenty":-15.201543,"median":-12.451899,"eighty":-6.368734,"marketCap":2223793556},{"date":"2026-08-14","current":-16.566431,"twenty":-15.503178,"median":-12.623979,"eighty":-6.396893,"marketCap":2272251624},{"date":"2026-08-21","current":-16.737832,"twenty":-15.582924,"median":-12.704769,"eighty":-6.419712,"marketCap":2295760985},{"date":"2026-08-28","current":-17.780229,"twenty":-15.689526,"median":-12.798103,"eighty":-6.426595,"marketCap":2438736277},{"date":"2026-08-31","current":-17.059646,"twenty":-15.697551,"median":-12.838427,"eighty":-6.427984,"marketCap":2339901008}],"updateTime":1788278370968},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RAPP\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662495741","title":"Rapport Therapeutics Chief Development Officer Krishnaswamy Yeleswaram Disposes of Common Shares Worth $2.51 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662495741","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662495741?lang=en_us&edition=fundamental","pubTime":"2026-08-27 04:00","pubTimestamp":1787774433,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics Chief Development Officer Krishnaswamy Yeleswaram disposes of common shares worth $2.51 millionRapport Therapeutics Chief Development Officer Yeleswaram Krishnaswamy sold 50,160 c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL9f4bFt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Rapport Therapeutics Chief Development Officer Krishnaswamy Yeleswaram Disposes of Common Shares Worth $2.51 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661127350","title":"Rapport Therapeutics to Host Virtual KOL Event on Bipolar Mania and RAP-219 Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2661127350","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661127350?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:02","pubTimestamp":1787569379,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics to host virtual KOL event on bipolar mania and RAP-219 programRapport Therapeutics will host a virtual KOL event on Sept. 22, 2026 at 12:30 p.m. ET.Discussion will center on bipol","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDLsc9Xv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","BK4007","SG9999014005.SGD","IE00BKPKM429.USD","BK4588","IE00BQXX3C00.GBP","LU0314104364.USD","LU2095319765.USD","BK4585","IE00BQXX3F31.USD","IE00BQXX3D17.EUR","IE00BN0W2V16.EUR","LU2210150020.SGD","RAPP","BCDF","NDAQ","SG9999014013.SGD","IE00B3QW5Z07.USD","BK4112","IE00BN0W2W23.USD","SG9999014039.USD","SG9999014021.USD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661234024","title":"Rapport Therapeutics Chief Development Officer Krishnaswamy Yeleswaram Disposes of 404 Common Shares Worth $20,159.6","url":"https://stock-news.laohu8.com/highlight/detail?id=2661234024","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661234024?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:09","pubTimestamp":1787256575,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics Chief Development Officer Krishnaswamy Yeleswaram disposes of 404 common shares worth $20,159.6Rapport Therapeutics Chief Development Officer Yeleswaram Krishnaswamy sold 404 comm","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL6zL9wn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Rapport Therapeutics Chief Development Officer Krishnaswamy Yeleswaram Disposes of 404 Common Shares Worth $20,159.6","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RAPP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660283706","title":"Analysts Have Conflicting Sentiments on These NA Companies: ServiceTitan, Inc. Class A (TTAN), Rapport Therapeutics, Inc. (RAPP) and Amentum Holdings, Inc. (AMTM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660283706","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660283706?lang=en_us&edition=fundamental","pubTime":"2026-08-20 18:20","pubTimestamp":1787221209,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the NA sector with new ratings on ServiceTitan, Inc. Class A (TTAN), Rapport Therapeutics, Inc. (RAPP) and ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-na-companies-servicetitan-inc-class-a-ttan-rapport-therapeutics-inc-rapp-and-amentum-holdings-inc-amtm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-na-companies-servicetitan-inc-class-a-ttan-rapport-therapeutics-inc-rapp-and-amentum-holdings-inc-amtm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4141","TTAN","BK4007","NA","RAPP","AMTM","BK4023","BK4123"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660402749","title":"Analysts Offer Insights on NA Companies: Rapport Therapeutics, Inc. (RAPP) and SpaceX (SPCX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660402749","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660402749?lang=en_us&edition=fundamental","pubTime":"2026-08-20 16:30","pubTimestamp":1787214623,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the NA sector with new ratings on Rapport Therapeutics, Inc. (RAPP) and SpaceX (SPCX). Rapport Therapeutics...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-rapport-therapeutics-inc-rapp-and-spacex-spcx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-rapport-therapeutics-inc-rapp-and-spacex-spcx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DXYZ","BK4615","UFO","SPCU","SPCX","SPCG","BK4089","MARS","BK4007","SNK","SPCF","LU1861215975.USD","ORBX","XOVR","LU1861558580.USD","LU1861220033.SGD","SSPC","WSPC","SPAL","LOFF","LU1861559042.SGD","SPCM","BK4141","LU2290526834.HKD","SPCH","RAPP","ELOL","LOFD","SPAX","SPCQ","NA","WARP","LU2360107168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660769334","title":"Does Widening Losses And Higher EPS Drag Change The Bull Case For Rapport Therapeutics (RAPP)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2660769334","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660769334?lang=en_us&edition=fundamental","pubTime":"2026-08-20 05:31","pubTimestamp":1787175091,"startTime":"0","endTime":"0","summary":"In August 2026, Rapport Therapeutics, Inc. reported second-quarter and half-year 2026 results showing a wider net loss, with Q2 net loss at US$56.62 million and basic loss per share from continuing operations at US$1.19, both higher than the prior year period.\nThe six-month net loss rising to US$76.47 million, alongside a higher loss per share of US$1.61, highlights how spending and earnings trends are weighing more heavily on the company’s financial profile.\nWe will assess how this widening...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rapp/rapport-therapeutics/news/does-widening-losses-and-higher-eps-drag-change-the-bull-cas","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rapp/rapport-therapeutics/news/does-widening-losses-and-higher-eps-drag-change-the-bull-cas","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["RAPP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660442301","title":"Rapport Therapeutics Price Target Maintained with a $65.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2660442301","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660442301?lang=en_us&edition=fundamental","pubTime":"2026-08-19 18:33","pubTimestamp":1787135580,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RAPP/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660438976","title":"Rapport Therapeutics price target raised to $75 from $68 at Raymond James","url":"https://stock-news.laohu8.com/highlight/detail?id=2660438976","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660438976?lang=en_us&edition=fundamental","pubTime":"2026-08-17 21:20","pubTimestamp":1786972808,"startTime":"0","endTime":"0","summary":"Raymond James analyst Tiago Fauth raised the firm’s price target on Rapport Therapeutics (RAPP) to $75 from $68 and keeps a Strong Buy rating on th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/rapport-therapeutics-price-target-raised-to-75-from-68-at-raymond-james-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/rapport-therapeutics-price-target-raised-to-75-from-68-at-raymond-james-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RAPP","RJF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659165294","title":"Rapport Therapeutics, Inc. (RAPP) Receives a Buy from Stifel Nicolaus","url":"https://stock-news.laohu8.com/highlight/detail?id=2659165294","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659165294?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:35","pubTimestamp":1786635330,"startTime":"0","endTime":"0","summary":"In a report released today, Paul Matteis from Stifel Nicolaus maintained a Buy rating on Rapport Therapeutics, Inc., with a price target of $56.00....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rapport-therapeutics-inc-rapp-receives-a-buy-from-stifel-nicolaus-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rapport-therapeutics-inc-rapp-receives-a-buy-from-stifel-nicolaus-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SF","BK4007","BK4127","RAPP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659188302","title":"Rapport Therapeutics CEO Abraham Ceesay Sells 51,499 Shares Worth $2.41 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659188302","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659188302?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:36","pubTimestamp":1786566986,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics CEO Abraham Ceesay sells 51,499 shares worth $2.41 millionRapport Therapeutics CEO Abraham Ceesay sold 51,499 common shares on Aug. 10-11.Sales prices ranged from USD 45.97 to USD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL7z48Ym:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Rapport Therapeutics CEO Abraham Ceesay Sells 51,499 Shares Worth $2.41 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659011609","title":"Rapport Therapeutics Price Target Raised to $66.00/Share from $40.00 by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2659011609","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659011609?lang=en_us&edition=fundamental","pubTime":"2026-08-13 01:08","pubTimestamp":1786554480,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RAPP/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659016329","title":"Douglas Tsao Boosts Rapport Therapeutics Price Target to $66 on Strong RAP-219 Differentiation and Robust Phase 2 Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2659016329","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659016329?lang=en_us&edition=fundamental","pubTime":"2026-08-13 00:55","pubTimestamp":1786553726,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Douglas Tsao has maintained their bullish stance on RAPP stock, giving a Buy rating on August 6. Douglas Tsao has given his...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/douglas-tsao-boosts-rapport-therapeutics-price-target-to-66-on-strong-rap-219-differentiation-and-robust-phase-2-data-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/douglas-tsao-boosts-rapport-therapeutics-price-target-to-66-on-strong-rap-219-differentiation-and-robust-phase-2-data-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RAPP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657639253","title":"Analysts Offer Insights on NA Companies: Rapport Therapeutics, Inc. (RAPP) and Honeywell Aerospace (HONA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657639253","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657639253?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:11","pubTimestamp":1786018283,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the NA sector with new ratings on Rapport Therapeutics, Inc. (RAPP) and Honeywell Aerospace (HONA). Rapport...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-rapport-therapeutics-inc-rapp-and-honeywell-aerospace-hona-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-rapport-therapeutics-inc-rapp-and-honeywell-aerospace-hona-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HONA","BK4187","RAPP","NA","BK4007","BK4141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657178635","title":"Truist Financial Keeps Their Buy Rating on Rapport Therapeutics, Inc. (RAPP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657178635","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657178635?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:37","pubTimestamp":1786016256,"startTime":"0","endTime":"0","summary":"In a report released today, Danielle Brill from Truist Financial maintained a Buy rating on Rapport Therapeutics, Inc., with a price target of $56....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/truist-financial-keeps-their-buy-rating-on-rapport-therapeutics-inc-rapp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/truist-financial-keeps-their-buy-rating-on-rapport-therapeutics-inc-rapp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RAPP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657552287","title":"Rapport Therapeutics Price Target Maintained with a $65.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2657552287","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657552287?lang=en_us&edition=fundamental","pubTime":"2026-08-06 02:51","pubTimestamp":1785955860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RAPP/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657540303","title":"Rapport Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657540303","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657540303?lang=en_us&edition=fundamental","pubTime":"2026-08-05 21:31","pubTimestamp":1785936701,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings SummaryRapport Therapeutics, Inc.RAPP.OQreported a quarterly adjusted loss of $1.19 per share for the quarter ended ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL8N442234:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RAPP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657154953","title":"Rapport Therapeutics Q2 EPS $(1.19) Misses $(0.96) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657154953","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657154953?lang=en_us&edition=fundamental","pubTime":"2026-08-05 19:24","pubTimestamp":1785929048,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics (NASDAQ:RAPP) reported quarterly losses of $(1.19) per share which missed the analyst consensus estimate of $(0.96) by 23.96 percent. This is a 58.67 percent decrease over losses of $(0.75) per","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/60943937/rapport-therapeutics-q2-eps-1-19-misses-0-96-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657546764","title":"Rapport Therapeutics Q2 FY26 Net Loss Widens to $56.6 Million; R&D Expense More than Doubled to $51.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657546764","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657546764?lang=en_us&edition=fundamental","pubTime":"2026-08-05 19:18","pubTimestamp":1785928687,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics Q2 FY26 net loss widens to $56.6 million; R&D expense more than doubled to $51.4 millionRapport Therapeutics posted a Q2 2026 net loss of $56.6 million, widening from $26.7 millio","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL9c1Str:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RAPP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657545238","title":"Rapport Therapeutics Reports Second Quarter 2026 Financials and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2657545238","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657545238?lang=en_us&edition=fundamental","pubTime":"2026-08-05 19:00","pubTimestamp":1785927603,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nTUACRYWT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","RAPP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655816388","title":"Rapport Therapeutics CEO Abraham Ceesay Sells 2,210 Shares Worth $92,999.37","url":"https://stock-news.laohu8.com/highlight/detail?id=2655816388","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655816388?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:05","pubTimestamp":1785355554,"startTime":"0","endTime":"0","summary":"Rapport Therapeutics CEO Abraham Ceesay sells 2,210 shares worth $92,999.37Rapport Therapeutics CEO Abraham Ceesay sold 2,210 common shares on July 27, 2026.Sales priced at USD 42.11 and USD 42.74.Dir","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nNDL9rMfGk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Rapport Therapeutics CEO Abraham Ceesay Sells 2,210 Shares Worth $92,999.37","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","RAPP"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":95,"code":"91000000","status":"200"}]}}